HVTN 702 explained
HVTN 702 was a clinical trial which the HIV Vaccine Trials Network organized to develop an HIV vaccine. In February 2020 the organizers halted the trial after finding no evidence of efficacy.[1] [2] [3]
Around December 2019 various media outlets reported that HVTN 702 could be an effective vaccine in preventing HIV.[4] [5]
In 2016 various media outlets announced the start of the research.[6] [7] [8]
HVTN 702 was based on outcomes of the RV 144 trial.[9]
External links
Notes and References
- Web site: Doughton . Sandi . 'Incredibly disappointing': Fred Hutch, feds end HIV vaccine trial after data shows no benefit . . 3 February 2020.
- Web site: Experimental HIV vaccine regimen ineffective in preventing HIV . National Institutes of Health (NIH) . EN . 3 February 2020.
- Web site: Russell . Sabin . Promising HIV vaccine fails to show efficacy, trial halted . Fred Hutch . en . 4 February 2020.
- Web site: Fitzsimons . Tim . HIV vaccine in 2021? Leading experts 'optimistic' about ongoing trials . NBC News . en . 1 December 2019.
- Web site: Lee . Bruce Y. . An HIV Vaccine By 2021? Here Is What Needs To Happen . Forbes . en . 3 December 2019.
- Web site: New HIV vaccine trial to start in South Africa . www.cbsnews.com . 28 November 2016.
- Web site: Galeon . Dom . An End to AIDS: New Vaccine Could Be The "Final Nail in the Coffin" for HIV . Futurism . en . 29 November 2016.
- Web site: HIV vaccine trial begins in South Africa . BBC News . 30 November 2016.
- Web site: Cairns . Gus . Another HIV vaccine efficacy trial will start this year . . en . 26 July 2017.